Celcuity 10Q 2020 Q1 Quarterly report | CELC Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: aberration, acquired, actin, adaptability, adaptive, Additionally, adjuvant, administered, administering, AEs, Afinitor, AG, agreed, AI, AIs, AKT, alpelisib, ALT, altered, amplification, Anderson, anemia, animal, anniversary, announced, Antonio, appetite, approach, arm, aromatase, arrest, assessment, AST, AstraZeneca, avoiding, baseline, bear, billion, biology, biosimilar, block, blockade, blockading, breach, broader, candidate, Cannon, capmatinib, care, carve, catalytic, CBR, CDK, CDKi, CDx, chart, choice, claim, collateral, commonly, compelling, compensatory, Comprehensive, comprising, concentration, confounding, contracted, contrast, convenience, Conversion, cooperating, country, create, criteria, criterion, crizotinib, crosstalk, cure, cured, customary, cutoff, cycle, cyclin, cycling, cytoskeletal, cytoskeleton, dacomitinib, dashed, database, decision, degrader, dephosphorylase, desirable, diarrhea, discontinuation, discontinued, distinct, division, domain, dormant, dose, dosed, dotted, doublet, downstream, dual, durable, dysegeusia, dysfunctional, earlier, effector, elapsed, endometrial, endpoint, epidermal, epigenetic, ER, escalation, escape, essential, estrogen, eventual, evidence, exclusive, exclusively, exclusivity, exemestane, expansion, expiration, expire, explain, extracellular, failure, fallen, Faslodex, fatigue, February, fee, feedback, feedforward, female, fewer, Food, formulation, fragmented, free, full, fulvestrant, gedatolisib, glucose, goal, good, greater, greatly, hematologic, Herzuma, high, higher, hormonal, hormone, Hospital, HR, human, hurdle, hyperglycemia, Ibrance, illustration, imaging, implant, implicated, Importantly, individual, induce, induced, inflammation, infusion, inherent, inhibit, inhibited, Inhibiting, inhibition, insolvency, Institute, integrated, interdependent, intracellular, intravenously, intrinsic, introduced, isoform, Jonsson, kinase, Korean, lack, landscape, large, lead, leader, leading, led, Lender, Lending, leptomeningeal, lesion, letrozole, leukopenia, level, Leveraging, license, licensed, licensing, line, linked, lipid, liquidity, listed, loading, loan, longer, low, LP, malignancy, mammalian, manner, manufacture, maximize, Maximizing, mBC, MD, mechanism, median, mediate, metabolism, mg, mitogenic, molecularly, molecule, monotherapy, motility, mouth, MRI, MTD, mTOR, mucosal, multiple, mutant, mutation, naive, nanomolar, narrower, National, nausea, neoadjuvant, neratinib, neutropenia, notice, NR, objective, optimal, ORR, OS, Overactivation, paired, palbocicib, palbociclib, paradoxical, partial, participant, participating, Perjeta, pertuzumab, Pfizer, PFS, phosphatidylinositol, phosphorylation, physiologic, pilot, Piqray, pivotal, plasma, population, potency, potent, PR, preferentially, preliminary, prepay, prepayment, prevalent, prevent, prevention, Prime, produced, profile, program, progressed, progression, progressive, proliferative, promising, promote, prompted, prostate, protein, protocol, PTEN, pursing, randomized, rapamycin, rash, rationale, reached, receipt, receptor, RECIST, rectum, reduction, regimen, regressed, regression, relapse, relief, repeatably, replication, resistance, resistant, restore, reversible, rinse, rod, royalty, Rx, San, Sarah, Schedule, Secondary, secured, security, seeding, separately, serve, shown, side, simultaneously, single, small, solid, sponsor, sponsored, stable, steroidal, strong, subcellular, sublicensable, subunit, sum, superior, supply, Symposium, synergy, Tabrecta, tamoxifen, tasked, Thirteen, tiered, titanium, tolerability, tolerated, toxicity, trailing, tranche, transcriptional, transduction, transmitted, transport, trastuzumab, triplet, tyrosine, UCLA, ultimately, unable, unconfirmed, undergo, undue, unrestricted, unselected, upfront, upregulation, upstream, utilize, visceral, vivo, Vizimpro, volume, vomiting, warrant, weekly, weighted, wide, worldwide, worsening, Wyeth, Xalkori, xenograft, xii, xiii, yielded

Removed: addressing, adjust, antibody, application, apply, ASC, Asia, ASU, bank, carry, China, classification, classified, colorectal, comparative, confidence, confirm, correlative, dead, deferred, define, detail, discovering, disrupt, diversion, economy, EGFR, eliminated, Erbitux, Europe, evolve, experiencing, extent, FASB, federal, fielding, fixed, forward, fourth, guidance, hire, implement, indirect, insight, interruption, likelihood, local, magnitude, mitigation, monitor, negatively, original, outcome, package, percentage, pioneering, practical, predicted, prescribing, productivity, quarantine, rapidly, recognition, recruit, reliance, remote, restate, retrospective, scope, significantly, specifically, Squibb, state, statistical, strain, testing, Topic, transform, translating, uncertain, volatile, withdrawing, World, Wuhan

	1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

	2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Dated: May 10, 2021	By	/s/ Vicky Hahne
		Vicky Hahne
		Chief Financial Officer

Celcuity (CELC) 10-Q2020 Q1 Quarterly report

Content analysis